Quest Diagnostics, Inc. (DGX)
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.
Recs
The Flu & VRML will make this move higher.
Recs
Underperformed the previous quarter and will steadily rise after irrational fear of healthcare legislation subsides
Recs
obamacare will make or break this stock
already cut to the bone employee wise
Recs
Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500
Recs
Medical diagnostics are on the up in the coming years. More and more posibilities to diagnose diseases by biomarkers and genetics - and this company is one of the big players
Recs
good defensive sector in current mkt (08/07/09)
Recs
Tests that no one else has...a moat...great ran company!
Recs
Medical Diagnostics will benefit from Obama's health care initive.
Recs
Quest Diagnostics has strength and weakness but it will be interesting to follow through on this time chain.
Recs
Performed relatively well during this bear market. As the market rebounds a bit, DGX won't rebound as fast as it has less "room to run" than many others in the SP500.
Recs
One of the major reference labs (LabCorp being the other) that nearly every physician office sends specimens to. Also processes lab tests that Hospitals cannot or will not do in-house (AKA the "Sendout"). I don't see their sales going anywhere anytime soon.
Recs
testing is going up all the time, docs can't seem to live without them
Recs
Reference labs tend to fair well when cost control comes into play
Recs
Solid Company. Biggest provider of diagnostic imaging services in the United States. I work in the healthcare field.
Recs
No-brainer. Solid stock, solid company, no so solid times.
Recs
A sure thing coming up right behind death and taxes: illness. As one of the biggest lab/diagnositic services in the country, Quest has solid earnings and ddividends and an 8% NET profit margin. Not too shabby. Having said all this, I'd also have to recommend their biggest competitor, labcorp, whose financials look even stronger.
Recs
solid cash holiding - strong vendor relationships
Recs
Growth is slow but steady. I use this service as a patient. Neither too pricy or cheap on service. Product is stable with elderly population growing, services a plus for medical community. Little concerned over P/E ratio but not too concerned
Recs
Any easy winner over the years... Maybe it will go down further but no point in trying to time the bottom as people head out for more and more medical tests everyday...
Recs
great company in its field. ression proof, stable,being number 1 in testing.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 73 1 2 3 4 Next »